Newron Pharmaceuticals Strikes Funding Deal Worth Up to 30 Million Swiss Francs

ZURICH, Dec 3 (Reuters) - Biotech company Newron Pharmaceuticals SpA has struck an equity funding agreement with YA Global Investments to raise up to 30 million Swiss francs ($25 million).